Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method of umbilical cord blood mesenchymal stem cell medicine for promoting knee joint cartilage regeneration

A technology of stem cells and chondrocytes, applied in the field of biomedicine, can solve the problems of prolonging the treatment time, increasing the pain of patients, and weak protection of articular cartilage, and achieve the effect of improving sustained release, reducing pain, and moisturizing and nourishing

Active Publication Date: 2021-03-30
深圳市莱利赛生物科技有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The use of umbilical cord mesenchymal stem cells in the prior art for therapeutic agents ensures the activity of umbilical cord mesenchymal stem cells as much as possible, so that it can promote the regeneration of damaged endogenous stem cells and differentiate into osteoblasts and chondrocytes. At the same time, it promotes the proliferation and replication of original chondrocytes, supplements and repairs damaged cartilage tissue; however, the protection of articular cartilage during treatment is relatively weak, which prolongs the treatment time and increases the pain of patients.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of umbilical cord blood mesenchymal stem cell medicine for promoting knee joint cartilage regeneration
  • Preparation method of umbilical cord blood mesenchymal stem cell medicine for promoting knee joint cartilage regeneration

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] A preparation method of umbilical cord blood mesenchymal stem cell medicine for promoting knee joint cartilage regeneration, said umbilical cord blood mesenchymal stem cell medicine comprises: 7% cord blood mesenchymal stem cell, 1% chondrocyte, 14% hyaluronic acid gel, 3% composite nanocellulose, 15% matrix liquid, 9% Chinese medicine extract slow-release microspheres, and the remaining microbubble lubricating fluid; wherein, the composite nanocellulose is composed of polypeptide nanocellulose, nanocrystalline fiber, quaternary ammonium The weight ratio of nano-cellulose is 3:2:1; quaternized nano-cellulose has good hydrophilicity and can be used as a good drug sustained-release material; polypeptide nano-cellulose is beneficial to cell proliferation and adhesion; Crystalline fibers: Nano-crystalline fibers have good elasticity, and also have a certain antioxidant effect, which can provide a low-oxygen microenvironment for cells. Wherein, the composite nanocellulose is...

Embodiment 2

[0067] A preparation method of umbilical cord blood mesenchymal stem cell medicine for promoting knee joint cartilage regeneration, said umbilical cord blood mesenchymal stem cell medicine comprises: 8% cord blood mesenchymal stem cell, 2% chondrocyte, 15.5% hyaluronic acid gel, 3.5% composite nanocellulose, 17.5% matrix liquid, 10% slow-release microspheres of traditional Chinese medicine extract, and the remaining microbubble lubricating fluid; wherein, the composite nanocellulose is composed of polypeptide nanocellulose, nanocrystalline fiber, quaternary ammonium The weight ratio of nano-cellulose is 3:2:1; quaternized nano-cellulose has good hydrophilicity and can be used as a good drug sustained-release material; polypeptide nano-cellulose is beneficial to cell proliferation and adhesion; Crystalline fibers: Nano-crystalline fibers have good elasticity, and also have a certain antioxidant effect, which can provide a low-oxygen microenvironment for cells. Wherein, the comp...

Embodiment 3

[0093] A preparation method of umbilical cord blood mesenchymal stem cell medicine for promoting knee joint cartilage regeneration, said umbilical cord blood mesenchymal stem cell medicine comprises: 9% cord blood mesenchymal stem cell, 3% chondrocyte, 17% hyaluronic acid gel, 4% composite nanocellulose, 20% matrix liquid, 11% slow-release microspheres of traditional Chinese medicine extract, and the remaining microbubble lubricating fluid; wherein, the composite nanocellulose is composed of polypeptide nanocellulose, nanocrystalline fiber, quaternary ammonium The weight ratio of nano-cellulose is 3:2:1; quaternized nano-cellulose has good hydrophilicity and can be used as a good drug sustained-release material; polypeptide nano-cellulose is beneficial to cell proliferation and adhesion; Crystalline fibers: Nano-crystalline fibers have good elasticity, and also have a certain antioxidant effect, which can provide a low-oxygen microenvironment for cells. Wherein, the composite ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses applications of an umbilical cord blood mesenchymal stem cell medicine in promoting the regeneration of the knee joint cartilage. The umbilical cord blood mesenchymal stem cellmedicine comprises the following ingredients: 7-9 % of umbilical cord blood mesenchymal stem cells, 1-3 % of cartilage cells, 14-17 % of hyaluronic acid gel, 3-4 % of composite nanocellulose, 15-20 %of substrate liquid, 9-11 % of traditional Chinese medicine extract sustained release microspheres, the balance of micro vacuole lubricating liquid. A preparation method of the umbilical cord blood mesenchymal stem cell medicine comprises the following steps: (1) activating the composite nanocellulose by adopting heparin; (2) preparing the cell matrix; (3) preparing the traditional Chinese medicine extract sustained release microspheres; (4) preparing the micro vacuole lubricating liquid; and (5) preparing the reagent. In short, the technical scheme has the advantages that the ratio is reasonable, the injured cartilage tissue can be effectively repaired, the cure rate is high, and the pain feeling of patients is small. The technical scheme has positive significance in drug research and clinical treatment, and has good social and economic benefits.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to a preparation method of umbilical cord blood mesenchymal stem cell medicine for promoting knee joint cartilage regeneration. Background technique [0002] Cartilage damage is one of the most common knee disorders. Because cartilage has no blood vessels, nerves, and lymphatic tissues, and its nutrients mainly come from the synovial fluid of the knee joint, these histological characteristics make the self-repair ability of cartilage damage extremely limited. Traumatic cartilage damage can cause pain and swelling in the patient's joints. If not treated in time, it will accelerate the degeneration of the joints and cause more serious dysfunction. [0003] At present, the clinical treatment effect is not good, mainly to relieve the pain of patients and improve the function of knee joint. The reason is that the pathogenesis of cartilage injury is not clear. Drug thera...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/906A61K36/90A61K36/896A61K35/28A61K9/00A61K47/36A61K47/38A61K47/14A61P19/02A61P19/08A61K35/50A61K35/618A61K35/32
CPCA61K9/0024A61K35/28A61K35/32A61K35/50A61K35/618A61K36/185A61K36/284A61K36/328A61K36/54A61K36/70A61K36/71A61K36/716A61K36/8945A61K36/896A61K36/90A61K36/906A61K47/14A61K47/36A61K47/38A61P19/02A61P19/08A61K2300/00
Inventor 宋芸娟胡士庶张治国
Owner 深圳市莱利赛生物科技有限公司